MEDIA, Pa., Aug. 9 /PRNewswire-FirstCall/ -- Synova Healthcare Group,
Inc. (OTC Bulletin Board: SNVH) today announced the appointment of two
non-employee directors to its Board of Directors. Joining the Board of
Directors, effective August 8th, 2007, are Alan B. Levin and J. Jeffrey
Fox. Mr. Levin and Mr. Fox will serve as directors until the Company's 2008
Annual Meeting of Stockholders, and until their successors are elected and
qualified.
Mr. Levin successfully led the Happy Harry's drug store chain from 1987
until it was acquired by the Walgreen Company in July 2007. During his
tenure, Happy Harry's grew from 19 to 76 stores, with locations in
Delaware, Maryland, Pennsylvania and New Jersey. Mr. Levin is a graduate of
Tulane University and the Delaware Law School of Widener University. He
previously served as the Executive Assistant and Counsel to United States
Senator William V. Roth, Jr. In 2001, Mr. Levin served as Chairman of the
National Association of Drug Stores. Mr. Levin is also a past member of the
Board of Directors of the United States Chamber of Commerce. Currently, Mr.
Levin serves as the Chairman of the Board of the Delaware State Chamber of
Commerce and a member of its Executive Committee. He is also a board member
of the American Red Cross of the Delmarva Peninsula and a member of the
Advisory Board of the University of Delaware's Lerner College of Business
and Economics.
Mr. Fox is President of Renard Capital, LLC. He serves as an advisor on
acquisitions, divestitures, capital formation and strategies to maximize
shareholder value. Mr. Fox has over 25 years of acquisition, divestiture,
finance and accounting experience, including fifteen years as chief
financial officer of several publicly-traded middle market companies. He is
also a founding member of Emerald Asset Management. Mr. Fox served for over
three years as Chairman of the Audit Committee on the Board of Directors of
Cimnet, Inc. He currently serves on the Library of Congress James Madison
Council, the William T. Walters Association of the Walters Art Museum, as
well as the board of directors of the Boys and Girls Clubs of Anne Arundel
County. Mr. Fox earned his B.S. degree from King's College and his MBA from
the University of Pittsburgh Katz Graduate School of Business. He is a
Certified Public Accountant and a Chartered Financial Analyst.
"We welcome the appointment of these esteemed professionals to our
Board," said Stephen King, Chairman and Chief Executive Officer of Synova
Healthcare Group, Inc. "We are pleased to have been able to attract such
directors with the depth and breadth of experience they bring to our
company. We look forward to the contributions of these two new directors as
we continue to execute our business strategy."
About Synova Healthcare Group, Inc.
Synova Healthcare Group, Inc. is committed to delivering innovative
products that provide meaningful improvements in women's healthcare.
Through its subsidiaries, it is focused on the development, distribution,
marketing and sale of women's healthcare products related to contraception,
vaginal health, menopause management, fertility planning, obstetrics and
personal care. Its goal is to provide healthcare solutions that address
every stage of a woman's life.
Synova currently markets and sells products under the brand names
Today(R), Fem-V(TM) and MenoCheck(R). The Today(R) Sponge is a hormone-free
contraceptive that combines barrier, spermicidal and absorptive methods to
prevent conception. Fem-V(TM) is a non-invasive diagnostic test designed to
assist women in detecting and diagnosing the presence of elevated vaginal
acidity, often indicating a vaginal infection. MenoCheck(R) is an in-home,
non-invasive diagnostic test used to detect and diagnose the onset of
menopause. For more information, please visit the Company's website at
http://www.synovahealthcare.com.
This Press Release may contain certain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
The Company has tried, whenever possible, to identify these forward-looking
statements using words such as "anticipates", "believes", "estimates",
"expects", "plans", "intends", "potential" and similar expressions. These
statements reflect the Company's current beliefs and are based upon
information currently available to it. Accordingly, such forward-looking
statements involve known and unknown risks, uncertainties and other factors
which could cause the Company's actual results, performance or achievements
to differ materially from those expressed in or implied by such statements.
Such risk factors are discussed in the Company's Form 10-KSB for the year
ended December 31, 2006, as filed with the Securities and Exchange
Commission on February 26, 2007, and the Company's Form 10-QSB for the
three months ended March 31, 2007, as filed with the SEC on May 18, 2007,
as well as in the Company's other periodic reports and filings with the
SEC. There can be no assurance that such factors will not affect the
accuracy of such forward- looking statements. The Company undertakes no
obligation to update or advise in the event of any change, addition or
alteration to the information set forth in this Press Release including
such forward-looking statements. This press release does not constitute an
offer to sell or the solicitation of an offer to buy; nor will there be any
sale of securities of Synova Healthcare Group, Inc. in any state where such
offer, solicitation or sale would be unlawful before registration or
qualification under the securities laws of those states.
|
